The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic

Detalles Bibliográficos
Autores principales: Wan, Marilyn T., Shin, Daniel B., Winthrop, Kevin L., Gelfand, Joel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American Academy of Dermatology, Inc. 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235584/
https://www.ncbi.nlm.nih.gov/pubmed/32416207
http://dx.doi.org/10.1016/j.jaad.2020.05.035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235584/
https://www.ncbi.nlm.nih.gov/pubmed/32416207
http://dx.doi.org/10.1016/j.jaad.2020.05.035

Ejemplares similares